Cecilia Nisticò

2.5k total citations
70 papers, 1.6k citations indexed

About

Cecilia Nisticò is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cecilia Nisticò has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 36 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cecilia Nisticò's work include Cancer Treatment and Pharmacology (44 papers), Breast Cancer Treatment Studies (34 papers) and HER2/EGFR in Cancer Research (23 papers). Cecilia Nisticò is often cited by papers focused on Cancer Treatment and Pharmacology (44 papers), Breast Cancer Treatment Studies (34 papers) and HER2/EGFR in Cancer Research (23 papers). Cecilia Nisticò collaborates with scholars based in Italy, United States and Malaysia. Cecilia Nisticò's co-authors include E. Terzoli, Diana Giannarelli, Francesco Cognetti, Emilio Bria, Federica Cuppone, Michèle Milella, Paolo Carlini, Isabella Sperduti, Alessandra Fabi and G. Ferretti and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Cecilia Nisticò

65 papers receiving 1.6k citations

Peers

Cecilia Nisticò

ONCOL

PRM

GENET

Paola Papaldo Italy

Massimo Lopez Italy

Peter Ang Singapore

Filipa Lynce United States

G. Peruzzotti Italy

Volker Möbus Germany

R. Theriault United States

Serafín Morales Spain

Linnea Chap United States

Lourdes Calvo Spain

Paola Papaldo Italy

Cecilia Nisticò

1.1k ×0.9

ONCOL

439 ×0.8

336 ×0.8

PRM

411 ×1.3

235 ×1.0

GENET

Citations per year, relative to Cecilia Nisticò Cecilia Nisticò (= 1×) peers Paola Papaldo

Countries citing papers authored by Cecilia Nisticò

Since Specialization

Citations

This map shows the geographic impact of Cecilia Nisticò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Nisticò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Nisticò more than expected).

Fields of papers citing papers by Cecilia Nisticò

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Nisticò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Nisticò. The network helps show where Cecilia Nisticò may publish in the future.

Co-authorship network of co-authors of Cecilia Nisticò

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Nisticò. A scholar is included among the top collaborators of Cecilia Nisticò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Nisticò. Cecilia Nisticò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferretti, G., et al.. (2021). Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases. Breast Care. 17(3). 330–335. 7 indexed citations

Fabi, Alessandra, G. Ferretti, Paola Malaguti, et al.. (2020). Nanoparticle Albumin-Bound Paclitaxel/Liposomal-Encapsulated Doxorubicin in HER2-Negative Metastatic Breast Cancer Patients. Future Oncology. 16(22). 1631–1639. 10 indexed citations

Fabi, Alessandra, Diana Giannarelli, Luca Moscetti, et al.. (2017). Ado-Trastuzumab Emtansine (T-DM1) in HER2+ Advanced Breast Cancer Patients: does Pretreatment with Pertuzumab Matter?. Future Oncology. 13(30). 2791–2797. 20 indexed citations

Giannarelli, Diana, G. Ferretti, Alessandra Fabi, et al.. (2015). Dose-finding study on a continuous dose of oral vinorelbine (VNR) in heavily pre-treated metastatic breast cancer (MBC) patients (pts). Annals of Oncology. 26. vi15–vi15.

Prodosmo, Andrea, Andrea De Amicis, Cecilia Nisticò, et al.. (2013). p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes. Journal of Clinical Investigation. 123(3). 1335–1342. 14 indexed citations

Fabi, Alessandra, Anna Di Benedetto, Giulio Metro, et al.. (2011). HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care. Clinical Cancer Research. 17(7). 2055–2064. 72 indexed citations

Novelli, Flavia, Michele Stanislaw Milella, Elisa Melucci, et al.. (2008). A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study. Breast Cancer Research. 10(5). R74–R74. 86 indexed citations

Cuppone, Federica, Emilio Bria, Paolo Carlini, et al.. (2008). Taxanes as primary chemotherapy for early breast cancer. Cancer. 113(2). 238–246. 47 indexed citations

Bria, Emilio, Federica Cuppone, Fabiana Letizia Cecere, et al.. (2007). Adjuvant Chemotherapy for Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2(5). S7–S11. 12 indexed citations

10.

Cuppone, Federica, Emilio Bria, Sunil Verma, et al.. (2007). Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer. Cancer. 112(2). 260–267. 87 indexed citations

11.

Bria, Emilio, Mariangela Ciccarese, Diana Giannarelli, et al.. (2006). Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: Pooled-analysis of 8794 patients. Cancer Treatment Reviews. 32(5). 325–332. 15 indexed citations

12.

Nisticò, Cecilia, Federica Cuppone, Emilio Bria, et al.. (2006). Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors. Anti-Cancer Drugs. 17(10). 1193–1200. 6 indexed citations

13.

Nisticò, Cecilia, F. Cognetti, Luciano Frontini, et al.. (2005). Weekly Docetaxel in Pretreated Metastatic Breast Cancer Patients: A Phase I-II Study. Oncology. 68(4-6). 356–363. 9 indexed citations

14.

Carlini, Paolo, Emilio Bria, Diana Giannarelli, et al.. (2005). New aromatase inhibitors as second‐line endocrine therapy in postmenopausal patients with metastatic breast carcinoma. Cancer. 104(7). 1335–1342. 21 indexed citations

15.

Garufi, Carlo, Emilio Bria, Cecilia Nisticò, et al.. (2005). Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients. European Journal of Cancer. 42(5). 608–616. 16 indexed citations

16.

Ferraresi, Virginia, Michèle Milella, Angela Vaccaro, et al.. (2000). Toxicity and Activity of Docetaxel in Anthracycline-Pretreated Breast Cancer Patients. American Journal of Clinical Oncology. 23(2). 132–139. 30 indexed citations

17.

Mottolese, Marcella, Maria Benevolo, Girolamo Del Monte, et al.. (2000). Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy. Journal of Cancer Research and Clinical Oncology. 126(12). 722–729. 17 indexed citations

18.

Nisticò, Cecilia, Carlo Garufi, Sandro Barni, et al.. (1999). Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancer. Annals of Oncology. 10(8). 937–942. 28 indexed citations

19.

Nisticò, Cecilia, Carlo Garufi, Michèle Milella, et al.. (1999). Weekly epirubicin plus lonidamine in advanced breast carcinoma. Breast Cancer Research and Treatment. 56(3). 231–235. 14 indexed citations

20.

Milella, Michele Stanislaw, Cecilia Nisticò, Virginia Ferraresi, et al.. (1999). Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women. Breast Cancer Research and Treatment. 55(3). 259–266. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact